Metoclopramide is used for the symptomatic treatment of post-operative or chemotherapy-induced nausea and vomiting, gastroesophageal reflux disease and gastroparesis. Metoclopramide is generally ...

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025 Gimoti remains only ...

Gastroparesis is a chronic disorder that affects a significant subset of the population. Diabetes mellitus is a risk factor for the development of gastroparesis. Currently, metoclopramide is the ...

Evoke Pharma (EVOK) underscores its commitment to patients and healthcare providers managing gastroparesis in light of FDA’s recent update ...

The definition of successful GPOEM varied across studies. The most common definitions were a one-point reduction in gastroparesis cardinal symptom index (GCSI), a one-point reduction in GCSI with a 25 ...

One of the key challenges in treating gastroparesis is ensuring effective drug absorption, as delayed stomach emptying often compromises the efficacy of orally administered medications. GIMOTI ...

Gastroparesis is most commonly associated with diabetes, but is also seen as a complication of other diseases and is also a recognised side effect of GLP-1 agonists used to treat diabetes and for ...

Dizziness can occur in relation to type 2 diabetes due to low or high blood sugar, diabetes medications, or dehydration. A doctor can help determine the cause and how to manage or treat it.

Diabetic socks are specially designed to keep feet dry, decrease the risk of foot injury, and enhance blood circulation. They are a key part of foot care, which is an important aspect of diabetes ...